| 期 |
标题 |
文件 |
| 卷 31, 编号 2 (2020) |
Clinical and epidemiological features of corpus uteri cancer |
|
|
Klinyshkova T.
|
| 卷 25, 编号 8 (2014) |
THE CLINICAL SAFETY AND IMMUNOLOGICAL EFFICACY OF THE RUSSIAN INFLUENZA VIROSOME-FORMULATED VACCINE ULTRIX® |
|
|
Kostlnov M., Tarasova A.
|
| 卷 26, 编号 9 (2015) |
CLINICAL AND LABORATORY DIAGNOSTICS OF STUNTING IN CHILDREN AND ADOLESCENTS |
|
|
Atanesyan R., Klimov L., Uglova T., Kurianinova V., Stouan M., Dolbnya S., Abramskaya L., Andreeva E., Saneeva G.
|
| 卷 18, 编号 8 (2007) |
Klinicheskaya otsenka primeneniya preparata «Klimadinon®» u onkologicheskikh bol'nykh (analiz rezul'tatov eksperimental'nogo nablyudeniya) |
|
|
Pokul' L., Porkhanova N.
|
| 卷 35, 编号 9 (2024) |
Clinical assessment of the respiratory system in pregnant women against the background of nicotine dependence |
|
|
Dzyubailo A., Lotkov V.
|
| 卷 31, 编号 12 (2020) |
Clinical features of extra-intestinal manifestations and optimization of treatment for celiac disease |
|
|
Ledensova S., Gulyaev N., Seliverstov P.
|
| 卷 26, 编号 11 (2015) |
CLINICAL EFFICACY OR ALGINATES IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE |
|
|
Blinkova L., Udovichenko T.
|
| 卷 27, 编号 12 (2016) |
CLINICAL EFFICACY AND SAFETY OF NICORANDIL: AN ADDITIONAL OPPORTUNITY TO IMPROVE THE TREATMENT OF PATIENTS WITH STABLE ANGINA |
|
|
Ryablkhln E., Mozhelko M., Krasilnikova Y.
|
| 卷 20, 编号 3 (2009) |
CLINICAL EFFICACY AND SAFETY OF BENF0LIPEN IN D0RS0PATHIES |
|
|
Kukes V., Shikh E., Makhova A., Kukes V., Shikh E., Makhova A.
|
| 卷 24, 编号 8 (2013) |
THE CLINICAL EFFICACY AND SAFETY OF MALTOFER |
|
|
Lovtsova L., Kuzin V., Osipova E.
|
| 卷 24, 编号 3 (2013) |
THE CLINICAL EFFECTIVENESS AND EFFECT OF EKVATOR ON TARGET ORGANS IN ARTERIAL HYPERTENSION |
|
|
Ginzburg M., Fokina A., Daniels E.
|
| 卷 31, 编号 4 (2020) |
The clinical efficiency of using Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis |
|
|
Peshekhonova L., Peshekhonov D., Krasyukov P.
|
| 卷 35, 编号 4 (2024) |
Clinical effectiveness of emollients with 30% urea and antiseptic Dorogov's stimulator in liposomal form in the complex therapy of chronic dermatoses |
|
|
Tlish M., Naatyzh Z., Kuznetsova T., Shavilova M.
|
| 卷 23, 编号 5 (2012) |
USE OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS: CLINICAL ASPECTS |
|
|
Kraeva V.
|
| 卷 36, 编号 7 (2025) |
Clinical variants of respiratory dysfunction in children with Fontan hemodynamic |
|
|
Shudueva A., Kovalev I., Mizernitskiy Y.
|
| 卷 33, 编号 4 (2022) |
Clinical variants of lesions of the nervous system in ANCA-associated vasculitis |
|
|
Oganov V., Mamykina S., Zinovyeva O., Strizhakov L., Novikov P., Moiseev S.
|
| 卷 35, 编号 6 (2024) |
Clinical and biochemical features of the course of COVID-19 in patients with arterial hypertension |
|
|
Mordyk A., Bagisheva N., Moiseeva M., Antipova E., Streltsova V.
|
| 卷 30, 编号 5 (2019) |
Clinical and histological characteristics of patients with gastric polyps |
|
|
Novikova A., Kolesnikova I.
|
| 卷 35, 编号 11 (2024) |
Clinical and laboratory features of metabolic syndrome in young indigenous and non-indigenous residents of Western Siberia (on the example of the Khanty-Mansiysk Autonomous Okrug – Yugra) |
|
|
Korneeva E., Voevoda M.
|
| 卷 34, 编号 4 (2023) |
Clinical and neuroimaging correlations in patients with chronic cerebrovascular disease and type 2 diabetes mellitus |
|
|
Belokopytova M., Dolgova I., Baturin V., Grigoryants I.
|
| 卷 29, 编号 11 (2018) |
Clinical and neurophysiological effects of topiramate in chronic migraine |
|
|
Shevchenko V., Artemenko A., Kurenkov A., Bzhllyansky M., Bushkov F.
|
| 卷 34, 编号 12 (2023) |
Clinical features and effectiveness of treatment of patients with pulmonary tuberculosis who have had COVID-19 |
|
|
Zakharov A., Karpina N., Chernykh N., Amansakhedov R., Stepanyan I., Romanov V., Ergeshov A.
|
| 卷 32, 编号 5 (2021) |
Clinical features of endometrial polyps in postmenopausal women |
|
|
Klinyshkova T., Frolova N., Soveyko E., Chernyshova N.
|
| 卷 27, 编号 11 (2016) |
CLINICAL FEATURES OF ACCESSORY BREAST CARCINOMA |
|
|
Zikiryakhodzhaev A., Ablitsova N., Shirokikh I., Ermakov A.
|
| 卷 36, 编号 8 (2025) |
Clinical manifestations of gastroesophageal reflux disease and anxiety in patients with metabolic syndrome |
|
|
Shrayner E., Kalashnikova K., Bystrova V., Lukichev D., Smirnova I., Sultanova A., Kudlay D.
|
| 卷 31, 编号 3 (2020) |
CLINICAL DIFFICULTIES IN THE DIAGNOSIS OF PRADER-WILLI SYNDROME |
|
|
Paramonova Y., Khalturina Y., Khruleva N., Khrulev A., Lyubavina N.
|
| 卷 29, 编号 11 (2018) |
Clinical analysis of iatrogenic diseases in the provision of medical care to patients with psoriasis |
|
|
Tlish M., Kuznetsova T., Naatyzh Z.
|
| 卷 36, 编号 7 (2025) |
Clinical experience with the comprehensive use of magnetic stimulation and robotic mechanotherapy in patients with sarcopenia due to motor disorders after stroke |
|
|
Kuznetsov K., Marchenkova L.
|
| 卷 34, 编号 3 (2023) |
A clinical case of amiodarone- and statin-induced neuropathy with a manifestation of chronic inflammatory demyelinating polyneuropathy |
|
|
Zaslavskii L., Zaslavskaya E., Petrov M., Skornyakova E.
|
| 卷 33, 编号 1 (2022) |
A clinical case of inflammatory cardiomyopathy due to experienced subacute viral myocarditis associated with the new coronavirus infection COVID-19 of occupational genesis |
|
|
Babanov S., Azovskaya T., Vakurova N., Lavrentyeva N., Baraeva R., Ryabov A., Agarkova A., Ostryakova N.
|
| 卷 34, 编号 7 (2023) |
A clinical case of an individual approach in the treatment of a patient with tuberculosis of the lungs and bronchus in combination with mycobacteriosis and Crohn's disease |
|
|
Chumovatov N., Polushkina E., Chernyh N., Sivokozov I., Komissarova O.
|
| 卷 34, 编号 8 (2023) |
A clinical case of morphea associated with Borrelia infection |
|
|
Abo Khadeejeh M., Olenich I., Niewozinska Z., Korsunskaya I.
|
| 卷 35, 编号 9 (2024) |
Clinical case of primary hyperaldosteronism with neuromuscular symptoms |
|
|
Orlova I., Orlova E., Kupriyanov S., Golenkov A., Bochkarev S., Orlov F.
|
| 卷 30, 编号 11 (2019) |
A clinical case of late diagnosis of ochronosis |
|
|
Chupakhina V., Bolshakova T., Kapustina E., Potupchik T., Boeva L., Pasechnik T., Shilova I., Bulygin G., Budarev A.
|
| 卷 34, 编号 5 (2023) |
A clinical case of late manifestation of celiac disease concurrent with another autoimmune disease |
|
|
Grinevich V., Kravchuk Y., Ivanyuk E., Seliverstov P., Yarovenko I., Karagodin I., Borisova A.
|
| 卷 33, 编号 11 (2022) |
A clinical case of a lesion of the central nervous system associated with a new coronavirus infection COVID-19: problems of diagnosis and examination of the connection with the profession of a medical worker |
|
|
Babanov S., Azovskova T., Lavrentyeva N.
|
| 卷 30, 编号 6 (2019) |
Clinical case of sequential endoprosthesis replacement of large joints with subsequent removal of pseudotumor elbow in a patient with severe hemophilia A |
|
|
Zorenko V., Polyanskaya T., Karpov E., Sadykova N., Koroleva A., Shuster A., Kudlay D., Borozinets A.
|
| 卷 35, 编号 11 (2024) |
Clinical case of the development of lipoid pneumonia due to diesel fuel poisoning |
|
|
Smirnov A., Mikhailov A., Velibekov R., Shevchenko A., Bugorskii I.
|
| 卷 29, 编号 8 (2018) |
A clinical case of sinonasal inverted papilloma |
|
|
Karpishchenko S., Vereshchagina O., Baranskaya S., Bibik P., Shumeiko V.
|
| 卷 26, 编号 3 (2015) |
CLINICAL VALUE OF ARTERIAL RIGIDITY IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION |
|
|
Kosheleva N., Ermakova T., Rebrov A.
|
| 卷 29, 编号 7 (2018) |
Pyoderma gangrenosum: a clinical case |
|
|
Nefedyeva Y., Ziganshin O., Kozavchinskaya N., Sysakov D.
|
| 卷 33, 编号 1 (2022) |
Clinical rationale for the use of autologous platelet-rich plasma during cesarean section |
|
|
Mazhidova Z., Yashchuk A., Musin I.
|
| 卷 26, 编号 6 (2015) |
ROLE OF [-2]proPSA AND ITS DERIVATIVES IN PROSTATE CANCER SCREENING IN MEN WITH A TOTAL PROSTATE-SPECIFIC ANTIGEN LEVEL OF 2-10 NG/ML |
|
|
Nevirovich E., Yakovenko A., Rumyantsev A., Budylev S., Selivanov A.
|
| 卷 36, 编号 3 (2025) |
Clinical application of Raman spectroscopy in gynecology |
|
|
Lystsev D., Kaptilny V., Zuev V., Chilova R.
|
| 卷 23, 编号 3 (2012) |
CLINICAL USE OF SANGUIRITRIN IN DYSBACTERIOSIS |
|
|
Vichkanova S., Krutikova N.
|
| 卷 34, 编号 4 (2023) |
The importance of monitoring viral activity and viral load of SARS-CoV-2 |
|
|
Burgasova O., Samkov A., Gushchin V., Tyurin I.
|
| 卷 5, 编号 2 (2005) |
KLOPIDOGREL'PRI OSTROM KORONARNOM SINDROME I ChRESKOZhNYKh KORONARNYKh VMEShATEL'STVAKh |
|
|
UDOVIChENKO A., SULIMOV V.
|
| 卷 28, 编号 2 (2017) |
KEY ISSUES IN THE TREATMENT OF IRON DEFICIENCY ANEMIA |
|
|
Dvoretsky L., Ivleva O.
|
| 卷 28, 编号 3 (2017) |
WHEN INVASIVE CARDIOLOGY METHODS ARE NOT APPLICABLE |
|
|
Vertkin A., Knorring G.
|
| 卷 29, 编号 9 (2018) |
Cognitive dysfunction in the overexcitation of brain structures |
|
|
Volobuev A., Pyatin V., Romanchuk N., Bulgakova S., Davydkin I.
|
| 卷 30, 编号 6 (2019) |
Cognitive rehabilitation in patients with type 1 diabetes mellitus |
|
|
Matveeva M., Samoilova Y., Zhukova N., Kudlay D., Ratkina K., Rotkank M., Leiman O., Fimushkina N.
|
| 卷 27, 编号 12 (2016) |
COGNITIVE CYTOKINE EFFECT OF ETORICOXIB IN OSTEOARTHRITIS: THE VECTOR STUDY |
|
|
Zolotovskaya I., Davydkln I.
|
| 卷 28, 编号 6 (2017) |
TYPES OF COGNITIVE DISORDERS IN THE PRACTICE OF A SPECIALIST OF ANTI-AGEING MEDICINE |
|
|
Sharova A.
|
| 卷 29, 编号 4 (2018) |
Cognitive impairment and cardiorespiratory dysfunction in dyscirculatory encephalopathy with cardiocerebral syndrome |
|
|
Golovkin V., Zuev A., Privalova M., Abakarov S.
|
| 卷 25, 编号 4 (2014) |
COGNITIVE IMPAIRMENTS IN ARTERIAL HYPERTENSION: POSSIBLE MECHANISMS OF OCCURRENCE AND PRINCIPLES OF THERAPY |
|
|
Voskresenskaya O., Zakharova N., Ivanov M.
|
| 卷 31, 编号 6 (2020) |
Cognitive impairment in older people: practical aspects of management |
|
|
Ekusheva E., Zaitseva O., Kuzina O.
|
| 卷 29, 编号 3 (2018) |
COGNITIVE IMPAIRMENT AND ANOSOGNOSIA IN THE ACUTE PERIOD OF ISCHEMIC STROKE |
|
|
Agafonova M., Maslova N., Agafonov K., Ulacen T.
|
| 卷 30, 编号 11 (2019) |
Cognitive impairment in comorbid patients with chronic brain ischemia and thyroid hypofunction |
|
|
Koldova T., Verbitskaya O., Baranova G., Petrova E., Vorobyeva E., Gorbunova A., Elistratov D., Poluboyarinov P.
|
| 卷 34, 编号 3 (2023) |
Cognitive impairment in obese patients: a pilot study. correction possibilities |
|
|
Gatskikh I., Potupchik T., Shalda T.
|
| 卷 23, 编号 3 (2012) |
COGNITIVE DEFICIT IN PATIENTS WITH METABOLIC SYNDROME |
|
|
Shlshkova V., Osychenko M.
|
| 卷 32, 编号 9 (2021) |
THE COGNITIVE DOMAIN OF INDIVIDUAL VIABILITY IN ELDERLY PATIENTS WITH HYPERTENSION |
|
|
Belousova O., Osipova O., Chupakha M., Voronina E., Ilnitski A., Korshun E.
|
| 卷 32, 编号 5 (2021) |
Cause-of-death coding as a factor influencing mortality rates from individual causes |
|
|
Samorodskaya I.
|
| 卷 36, 编号 4 (2025) |
Skin test with recombinant tuberculosis allergen in early diagnosis of tuberculosis infection |
|
|
Russkikh O., Kudlay D., Vaganova U., Doktorova N., Kryvasheyeva Z.
|
| 卷 28, 编号 8 (2017) |
SKIN TOXICITY OF CHEMOTHERAPY AND CUTANEOUS MANIFESTATIONS OF CHRONIC GRAFT VERSUS HOST REACTION. THE PRINCIPLES OF NON-DRUG CORRECTION OF SKIN LESIONS |
|
|
Potekaev N., Trakhtman P., Passokhina O., Shuginina E., Ivanova L.
|
| 卷 27, 编号 4 (2016) |
KOKARNIT: AN ANALGESIC POTENTIAL IN THE TREATMENT OF DIABETIC POLYNEUROPATHY |
|
|
Shikh E., Kukes V., Petunina N.
|
| 卷 32, 编号 1 (2021) |
Coccygodynia: etiology, diagnosis, and treatment |
|
|
Yarikov A., Perlmutter O., Sosnin A., Leonov V., Fraerman A., Mukhin A., Pardaev S.
|
| 卷 23, 编号 8 (2012) |
COLORECTAL CANCER IN OBESITY: PATHOGENETIC ASPECTS |
|
|
Stanoevlch U., Dekhlssl E., Chkhlkvadze V.
|
| 卷 26, 编号 7 (2015) |
COMBINATION THERAPY WITH L-LYSINE AESCINAT AND THIOTRIAZOLINE IN THE TREATMENT OF VERTEBRAL PAIN SYNDROMES IN THE CERVICAL SPINE IN PATIENTS WITH GASTROINTESTINAL DISORDERS |
|
|
Tynterova A., Kovalchuk V.
|
| 卷 24, 编号 3 (2013) |
A COMBINATION OF AMLODIPINE AND ATORVASTATIN IN CARDIOVASCULAR RISK REDUCTION |
|
|
Dedov D., Mukallov N., Evtyukhln I.
|
| 卷 31, 编号 6 (2020) |
A combination of hyperbaric oxygenation and Osteomed in the treatment of convulsive muscle contractions of the lower extremities |
|
|
Temnikov V., Tokarev A., Vovk E.
|
| 卷 28, 编号 12 (2017) |
COMBINATION ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS WITH RENAL DYSFUNCTION |
|
|
Khamidullaeva G., Abdullaeva G., Nizamov U., Ziyaeva A.
|
| 卷 29, 编号 11 (2018) |
Combined lipid-lowering therapy in patients with nonalcoholic fatty liver disease |
|
|
Seliverstov P., Sitkin S., Radchenko V., Tsurtsumla D., Dzhadzhav S.
|
| 卷 23, 编号 3 (2012) |
COMBINATION ANTIHYPERTENSIVE THERAPY FOR MILD-TO-MODERATE ARTERIAL HYPERTENSION AND CONCOMITANT CORONARY HEART DISEASE |
|
|
Cheremushkin S., Kucheryavyi Y., Oganesyan T.
|
| 卷 23, 编号 4 (2012) |
COMBINED NEUROPROTECTIVE THERAPY FOR CEREBROVASCULAR DISEASES |
|
|
Putilina M.
|
| 卷 30, 编号 5 (2019) |
Combination antiviral therapy of herpes simplex |
|
|
Vikulov G., Voznesenskiy S.
|
| 卷 23, 编号 7 (2012) |
COMBINATION THERAPY FOR ARTERIAL HYPERTENSION: REALITIES OF CLINICAL PRACTICE |
|
|
Lutoshkin M., Smirnova E., Kuzmenko O., Ryukhina I.
|
| 卷 23, 编号 3 (2012) |
COMBINATION THERAPY IS A SIGNIFICANT STEP FORWARD FOR TREATING ARTERIAL HYPERTENSION |
|
|
Poteshkina N., Pravdivtseva E., Khashiyeva F.
|
| 卷 28, 编号 8 (2017) |
COMBINED THERAPY FOR PANIC DISORDERS IN CARDIOLOGY PRACTICE |
|
|
Vasilyeva A., Karavaeva T., Poltorak S.
|
| 卷 29, 编号 3 (2018) |
COMBINED THERAPY FOR CHRONIC PROSTATITIS AND PROSTATIC ADENOMA |
|
|
Yakovets Y.
|
| 卷 27, 编号 4 (2016) |
COMBINED THERAPY FOR RESISTANT SUPRAVENTRICULAR TACHYARRHYTHMIA |
|
|
Ardashev A., Kozyrev O., Zubkov S., Litvinova I., Shpakov A.
|
| 卷 27, 编号 8 (2016) |
COMBINED TREATMENT FOR OSTEOARTHRITIS OF THE TEMPOROMANDIBULAR JOINT |
|
|
Tarasov I., Yudin D., Nikitin A., Chukumov R., Perova N.
|
| 卷 28, 编号 10 (2017) |
COMBINED TREATMENT FOR CHRONIC MIGRAINE: BOTULINUM TOXIN TYPE A AND VENLAFAXINE |
|
|
Tatarinova K., Artemenko A.
|
| 卷 27, 编号 1 (2016) |
COADMINISTRATION OF HETEROGENEOUS BIOPOLYMER HYDROGEL AND HYALURONIC ACID IN OSTEOARTHRITIS: THE FIRST EXPERIENCE |
|
|
Solovyeva I., Shesternya N., Perova N., Sevastyanov V.
|
| 卷 23, 编号 7 (2012) |
COMBINED B-GROUP VITAMINS FOR DIABETIC POLYNEUROPATHY |
|
|
Alekseev A.
|
| 卷 28, 编号 11 (2017) |
COMBINED OPERATIONS IN THORACIC ONCOLOGY |
|
|
Bazarov D.
|
| 卷 23, 编号 11 (2012) |
COMBINED DRUGS AND ENHANCEMENT OF THE SAFETY OF THERAPY FOR INTENSIVE PAIN |
|
|
Pchelintsev M.
|
| 卷 27, 编号 3 (2016) |
Kommunikativnye navyki vracha |
|
|
Reze A.
|
| 卷 27, 编号 5 (2016) |
COMMUNICATING SKILLS. TRAINING OF PATIENTS |
|
|
Reze A.
|
| 卷 26, 编号 12 (2015) |
COMMUNICATING SKILLS. SHOULD A PATIENT BE INTERRUPTED WHEN DESCRIBING HIS COMPLAINTS? |
|
|
Reze A.
|
| 卷 27, 编号 2 (2016) |
COMMUNICATING SKILLS. THE STRUCTURE OF MEDICAL CONSULTATION |
|
|
Reze A.
|
| 卷 32, 编号 8 (2021) |
Comorbid pathology in children with autism spectrum disorders |
|
|
Chernova L.
|
| 卷 35, 编号 8 (2024) |
Comorbidity of asthenic syndrome and primary headaches in students of a medical university |
|
|
Akhmedova K., Mirzaeva L., Zuev A.
|
| 卷 27, 编号 3 (2016) |
COMORBIDITY OF DYSCIRCULA TORY ENCEPHALOPATHY WITH DIABETIC POLYNEUROPATHY, FRONTAL ATAXIA, AND BLOOD LEVELS OF TRACE ELEMENTS |
|
|
Prokopovich O., Torshin I., Gromova O., Gusev E., Nikonov A.
|
| 卷 28, 编号 7 (2017) |
COMORBIDITY AND POLYPRAGMACY |
|
|
Shlshkova V.
|
| 卷 32, 编号 3 (2021) |
Comorbidity and polypharmacy in the practice of a general practitioner |
|
|
Polozova E., Skvortsov V., Aksenova S., Zinyakov D., Levina T., Nefedov N., Narvatkina M.
|
| 卷 29, 编号 1 (2018) |
Comorbidity in patients with type 2 diabetes mellitus |
|
|
Voloshinova E., Lobanova O., Kunitsyna M., Grlgoryeva E., Tsaturova K.
|
| 卷 31, 编号 9 (2020) |
Prevalence, risk factors, and diagnosis of comorbidity of chronic obstructive pulmonary disease and cardiovascular disease |
|
|
Chaulin A., Milyutin I., Duplyakov D.
|
| 卷 35, 编号 10 (2024) |
Comorbid associations and risk factors for uncontrolled bronchial asthma in adolescents |
|
|
Evert L., Potupchik T., Muravyova N., Kuvshinova E., Kostyuchenko Y.
|
| 卷 31, 编号 3 (2020) |
A COMORBID PATIENT: RHEUMATOID ARTHRITIS AND HYPERTENSION |
|
|
Bazina I., Kozyrev O., Pavlova M., Krechikova D., Mizyova E., Pak D., Petrunina N.
|
| 卷 28, 编号 10 (2017) |
COMORBID OSTEOPOROSIS: CHALLENGES AND NEW DIAGNOSTIC OPPORTUNITIES (Part 1) |
|
|
Jones O., Strukov V., Kislov A., Eremina N., Kondrachenko M., Kuptsova T.
|
| 1101 - 1200 的 3477 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 > >> |
